Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 1999

View Archived Issues

Cypros receives notice of patent allowance for Cordox as a cardioprotective positive inotrope

Aradigm issued method patent for pulmonary insulin delivery

Aquila reveals new product in pipeline: CD1-TB

Nabi receives FDA approval, launches anti-hepatitis B product

FK-1052 inhibits delayed emesis in dogs

[99mTc]-Infecton: a fluorquinolone-based agent for imaging skin and soft tissue infections

AMBI's Chromax demonstrates safety and efficacy in treatment of diabetes

Therapeutically useful PDE4 inhibitors in development at ADIR

Inhibitors of the formation of AGTs described by Alteon

Patent issued for new Merck glucagon antagonists

MR-2917: novel central muscle relaxant synthesized at Maruho

CRC presents results of R&D in the area of protein prenylation inhibitors at ACS meeting

(+)-SNAP-6991 discovered at Synaptic and Merck as orally active, uroselective alpha1a blocker

Cypress Bioscience closes partnership agreement with Fresenius

New oral SLE therapy GL-701 awarded fast track designation

Anika to initiate Orthovisc phase III clinical study in U.S. and Canada

Phase II trials of first anticancer dioxolane nucleoside analogue begin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...